stockrowClover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) P/B ratio
As of 6 November 2026, Clover Health Investments, Corp. (CLOV) trades at a P/B ratio of 6.5×. Over the past ten years it has ranged from 0.0× (March 2021) to 132,258× (June 2020); the current reading is higher than 82% of that period. That is above the Healthcare Plans industry median of 2.8× and above the Healthcare sector median of 2.3×.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 3.9× | (13.87%) |
| FY2024 | 4.5× | 179.94% |
| FY2023 | 1.6× | 27.50% |
| FY2022 | 1.3× | (55.49%) |
| FY2021 | 2.8× | — |
| FY2020 | 0.0× | — |
| FY2019 | 121,754× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 5.9× | (19.70%) |
| Jun 2026 | 7.3× | 169.62% |
| Mar 2026 | 2.7× | (30.53%) |
| Dec 2025 | 3.9× | (15.31%) |
| 23 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| CNC Centene Corporation compare | 1.5× |
| CI Cigna Group compare | 1.8× |
| ELV Elevance Health, Inc. compare | 2.1× |
| MOH Molina Healthcare, Inc compare | 2.6× |
| HUM Humana Inc. compare | 2.8× |
| OSCR Oscar Health, Inc. compare | 4.3× |
| ALHC Alignment Healthcare, Inc. compare | 5.5× |
| PGNY Progyny, Inc. compare | 6.4× |
| CLOV Clover Health Investments, Corp. | 6.5× |
| Healthcare Plans industry median | 2.8× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement